Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Variant allele frequency as a potential marker in response to frontline systemic therapy for patients with locally advanced and metastatic urothelial carcinoma.
Journal: Translational andrology and urology
Published: January 06, 2026
Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer: A Meta-Analysis.
Journal: JAMA oncology
Published: November 20, 2025
Age and Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer.
Journal: NEJM evidence
Published: October 28, 2025
Non-Immunotherapy Arm Allocations in Phase 3 Genitourinary Cancer Trials with Immunotherapy.
Journal: Clinical genitourinary cancer
Published: October 25, 2025
EXTRA-PC: a phase II trial of masofaniten (EPI-7386) and enzalutamide for patients with treatment-naïve metastatic hormone-sensitive prostate cancer.
Journal: The oncologist
Published: October 11, 2025
Durable responses to immune checkpoint inhibitor-based regimens for metastatic clear cell renal cell carcinoma stratified by IMDC risk groups: A pooled analysis of four randomized phase 3 trials.
Journal: Kidney cancer (Clifton, Va.)
Published: July 01, 2025
Advanced urothelial carcinoma treated with enfortumab vedotin and pembrolizumab: a path to cure?
Journal: The oncologist
Published: February 10, 2025
Effect of Prior Prostate Directed Local Therapy on Response to Apalutamide in Metastatic Hormone Sensitive Prostate Cancer: A Secondary Analysis of the TITAN Study.
Journal: European urology
Published: December 11, 2023
Systematic review of recent advancements in antibody-drug and bicycle toxin conjugates for the treatment of urothelial cancer.
Journal: Therapeutic advances in urology
Published: October 11, 2023
A survey of patients with cancer and oncology health-care professionals about cannabis use during treatment.
Journal: Journal of the National Cancer Institute. Monographs
Published: July 31, 2023
Longitudinal Monitoring of Circulating Tumor DNA to Assess the Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Genitourinary Malignancies.
Journal: JCO precision oncology
Published: July 19, 2023
Last Updated: 09/26/2026